지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.1
- 수록면
- 10 - 16 (7page)
이용수
초록· 키워드
오류제보하기
Objectives: The aim of this study was to compare the compliance, efficacy, and satisfaction associated with methylphenidate and atomoxetine for treating attention-deficit/hyperactivity disorder (ADHD).
Methods: The subjects were 44 patients who met the Diagnostic and Statistical Manual of Mental Disorder-5 diagnostic criteria for ADHD and were treated with methylphenidate or atomoxetine. The methylphenidate formulations included immediate release (IR), extended release (ER), and osmotic-controlled release oral delivery system (OROS). Patients and parents reported the average number of days per week the medication was taken. Efficacy was assessed using the ADHD Rating Scale. Satisfaction with medication scale (SAMS)–parent report form and SAMS–self-report form were used to evaluate parents’ and patients’ satisfaction, respectively.
Results: Patients and parents were more satisfied with methylphenidate than with atomoxetine. There were no significant differences in the compliance with and efficacy of methylphenidate and atomoxetine. Compliance with methylphenidate IR and ER was markedly lower than that with OROS methylphenidate or atomoxetine.
Conclusion: Methylphenidate OROS formulation can be considered a suitable option given its high rates of compliance, satisfaction, and efficacy.
Methods: The subjects were 44 patients who met the Diagnostic and Statistical Manual of Mental Disorder-5 diagnostic criteria for ADHD and were treated with methylphenidate or atomoxetine. The methylphenidate formulations included immediate release (IR), extended release (ER), and osmotic-controlled release oral delivery system (OROS). Patients and parents reported the average number of days per week the medication was taken. Efficacy was assessed using the ADHD Rating Scale. Satisfaction with medication scale (SAMS)–parent report form and SAMS–self-report form were used to evaluate parents’ and patients’ satisfaction, respectively.
Results: Patients and parents were more satisfied with methylphenidate than with atomoxetine. There were no significant differences in the compliance with and efficacy of methylphenidate and atomoxetine. Compliance with methylphenidate IR and ER was markedly lower than that with OROS methylphenidate or atomoxetine.
Conclusion: Methylphenidate OROS formulation can be considered a suitable option given its high rates of compliance, satisfaction, and efficacy.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
CONCLUSION
REFERENCES
참고문헌 (26)
참고문헌 신청
American Psychiatric Association / 2013 / Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed / American Psychaitric Association
김효원 / 2017 / 주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(III) - 약물치료 - / 소아 청소년 정신의학 28(2):70~83
김진선 / 2010 / ADHD 환자에 대한 OROS-Methylphenidate 약물치료의 부작용과 관련요인들에 대한 연구 / 소아 청소년 정신의학 21(2):63~71
Kratochvil CJ / 2008 / Acute atomoxetine treatment of younger and older children with ADHD : a meta-analysis of tolerability and efficacy / Child Adolesc Psychiatry Ment Health 2:25
Kratochvil CJ / 2002 / Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial / J Am Acad Child Adolesc Psychiatry 41:776~784
김효원 / 2017 / 주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(III) - 약물치료 - / 소아 청소년 정신의학 28(2):70~83
김진선 / 2010 / ADHD 환자에 대한 OROS-Methylphenidate 약물치료의 부작용과 관련요인들에 대한 연구 / 소아 청소년 정신의학 21(2):63~71
Kratochvil CJ / 2008 / Acute atomoxetine treatment of younger and older children with ADHD : a meta-analysis of tolerability and efficacy / Child Adolesc Psychiatry Ment Health 2:25
Kratochvil CJ / 2002 / Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial / J Am Acad Child Adolesc Psychiatry 41:776~784
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
주의력결핍과잉행동장애의 약물요법
대한의사협회지
2019 .01
-
Treatment of Children and Adolescents with Epilepsy with Atomoxetine
PSYCHIATRY INVESTIGATION
2020 .01
-
Clinical and Neuropsychological Factors Associated with Treatment Response and Adverse Events of Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder
소아청소년정신의학
2019 .04
-
Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion
Journal of Clinical Neurology
2023 .03
-
Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database
Journal of Korean Medical Science
2016 .01
-
Effects of Atomoxetine on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
PSYCHIATRY INVESTIGATION
2018 .01
-
Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
Clinical Psychopharmacology and Neuroscience
2020 .01
-
Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
Clinical Psychopharmacology and Neuroscience
2016 .01
-
성인 주의력결핍과잉행동장애의 약물치료
대한의사협회지
2021 .01
-
Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder
Clinical Psychopharmacology and Neuroscience
2021 .11
-
The Effectiveness of Methylphenidate in the Treatment of Encopresis Independent from Attention-Deficit Hyperactivity Disorder Symptoms
PSYCHIATRY INVESTIGATION
2015 .01
-
Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report
Clinical Psychopharmacology and Neuroscience
2015 .01
-
Acute Dystonia Following a Switch in Treatment from Atomoxetine to Low-dose Aripiprazole
Clinical Psychopharmacology and Neuroscience
2016 .01
-
A Review and an Update on Pharmacological Treatment of Children With Attention-Deficit/Hyperactivity Disorder
소아청소년정신의학
2025 .01
-
국내 주의력결핍 과잉행동 장애 아동 및 청소년의 약물요법 패턴 및 지속성
한국임상약학회지
2018 .01
-
Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
소아청소년정신의학
2023 .04
-
Naturalistic Pharmacotherapy Compliance among Pediatric Patients with Attention Deficit/Hyperactivity Disorder: a Study Based on Three-Year Nationwide Data
Journal of Korean Medical Science
2016 .01
-
국민건강보험 데이터베이스를 이용한 한국의 소아와 성인에서 주의력결핍 과잉행동장애의 진단율 및 약물 사용 추세 연구
신경정신의학
2021 .11
-
주의력결핍 과잉행동장애 한국형 치료 권고안 개정안(Ⅲ) : 약물치료
소아청소년정신의학
2017 .04
-
Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder
소아청소년정신의학
2022 .04
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2021-516-001469657